Kymera Therapeutics, Inc.
KYMR
$117.39
$2.972.60%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.15% | -23.26% | 67.75% | -24.01% | 43.68% |
| Total Receivables | -- | -- | -- | -- | 100.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -0.84% | 15.54% | 1.42% | -1.16% | 28.54% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 8.83% | -22.24% | 64.91% | -27.46% | 45.39% |
|
|
|||||
| Total Current Assets | 8.83% | -22.24% | 64.91% | -27.46% | 45.39% |
| Net Property, Plant & Equipment | -2.74% | -2.54% | -2.89% | -6.91% | -1.34% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.22% | -9.43% | 18.21% | 20.21% | 15.08% |
| Total Assets | -1.41% | -4.23% | 58.14% | -2.57% | 23.17% |
|
|
|||||
| Total Accounts Payable | -30.54% | 219.78% | -27.08% | -4.76% | -43.67% |
| Total Accrued Expenses | 38.13% | -16.98% | 47.61% | 2.37% | 21.02% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.27% | -0.17% | 0.09% | 0.56% | 3.22% |
| Total Finance Division Other Current Liabilities | -75.82% | -95.79% | -2.20% | -40.96% | 224.34% |
| Total Other Current Liabilities | -75.82% | -95.79% | -2.20% | -40.96% | 224.34% |
| Total Current Liabilities | 13.86% | -24.72% | 16.26% | -18.24% | 48.40% |
|
|
|||||
| Total Current Liabilities | 13.86% | -24.72% | 16.26% | -18.24% | 48.40% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.81% | -2.57% | -2.50% | -2.49% | -1.43% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -18.03% | -- | -- |
| Total Liabilities | 5.26% | -20.70% | 4.73% | -2.38% | 20.83% |
|
|
|||||
| Common Stock & APIC | 1.26% | 1.33% | 37.43% | 2.98% | 16.28% |
| Retained Earnings | -5.39% | -6.49% | -8.88% | -9.16% | -9.34% |
| Treasury Stock & Other | -70.65% | -333.00% | 19.92% | 437.99% | 581.03% |
| Total Common Equity | -1.97% | -2.53% | 66.94% | -2.60% | 23.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.97% | -2.53% | 66.94% | -2.60% | 23.56% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.97% | -2.53% | 66.94% | -2.60% | 23.56% |
|
|
|||||